Simeakis, G.; Anagnostouli, M.; Fakas, N.; Koutsikos, J.; Papatheodorou, A.; Chanopoulos, K.; Athanasiou, K.; Papatheodorou, G.; Zapanti, E.; Alevizaki, M.;
et al. High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study. Biomedicines 2023, 11, 603.
https://doi.org/10.3390/biomedicines11020603
AMA Style
Simeakis G, Anagnostouli M, Fakas N, Koutsikos J, Papatheodorou A, Chanopoulos K, Athanasiou K, Papatheodorou G, Zapanti E, Alevizaki M,
et al. High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study. Biomedicines. 2023; 11(2):603.
https://doi.org/10.3390/biomedicines11020603
Chicago/Turabian Style
Simeakis, George, Maria Anagnostouli, Nikolaos Fakas, John Koutsikos, Athanasios Papatheodorou, Konstantinos Chanopoulos, Kwnstantinos Athanasiou, George Papatheodorou, Evangelia Zapanti, Maria Alevizaki,
and et al. 2023. "High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study" Biomedicines 11, no. 2: 603.
https://doi.org/10.3390/biomedicines11020603
APA Style
Simeakis, G., Anagnostouli, M., Fakas, N., Koutsikos, J., Papatheodorou, A., Chanopoulos, K., Athanasiou, K., Papatheodorou, G., Zapanti, E., Alevizaki, M., Kaltsas, G., & Terpos, E.
(2023). High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study. Biomedicines, 11(2), 603.
https://doi.org/10.3390/biomedicines11020603
